DaviesT. Growing an interest in autoimmune thyroid disease—an interview with Robert Volpe MD. Endocrinol Metab Clin North Am, 2000; 29(2):431–442.
2.
DaviesT. A thyroid-stimulating life: An interview with Dr. J. Maxwell McKenzie. Thyroid, 2001; 11(11):1035–1042.
3.
DaviesT. Braverman’s thyroid—An interview with Lewis Braverman. Thyroid, 2005; 15(3):188–196.
4.
DaviesTF. The scientific contributions of Martin Surks, MD, MACP: A pioneer in thyroid hormone physiology, subclinical hypothyroidism, and endocrine education. Thyroid, 2022; 32(7):745–749.
5.
DaviesTF. The active times of Jerome Hershman, MD: An interview with the founding editor of thyroid about a life devoted to the thyroid gland (and other things). Thyroid, 2021; 31(11):1609–1612.
6.
DaviesTF. An accidental thyroidologist: Sandra McLachlan, PhD. Thyroid, 2024; 34(3):281–287.
7.
DaviesTF. A discussion with Leonard Wartofsky, MD: Teacher, clinician, investigator, mentor of many, a medical politician, and guest editor of thyroid volume 1 number 1. Thyroid, 2023; 33(12):1387–1392.
8.
DaviesTF. A conversation with Samuel Refetoff, MD: How treating one family stimulated a lifelong series of major discoveries in thyroid physiology and disease. Thyroid, 2024; 34(10):1187–1193.
9.
DaviesTF. Valerie Anne Galton PhD: A Rosalind Pitt Rivers protege by pure luck!. Thyroid, 2025; 35(6):599–606.
10.
SchneiderAB, BornetH, EdelhochH. Properties of thyroglobulin. XX. The biosynthesis of thyroglobulin. Effect of temperature on subunit species. J Biol Chem, 1970; 245(10):2673–2678.
11.
SchneiderAB, EdelhochH. The properties of thyroglobulin. XIX. The equilibrium between guinea pig thyroglobulin and its subunits. J Biol Chem, 1970; 245(4):885–890.
12.
CorteseF, SchneiderAB, SalvatoreG. Isopycnic centrifugation of thyroid iodoproteins: Selectivity of endocytosis. Eur J Biochem, 1976; 68(1):121–129.
13.
WellsSAJr, GunnellsJC, ShelburneJD, et al.Transplantation of the parathyroid glands in man: Clinical indications and results. Surgery, 1975; 78(1):34–44.
14.
SchneiderAB, WellsSA, GunnellsJC, et al.Regulation of function of transplanted parathyroid glands in man. Am J Med, 1977; 63(5):710–718.
15.
SchneiderAB, KowalskiK, BuckmanG, et al.Dimeric (“big”) human placental lactogen. Immunological and biological activity. Biochim Biophys Acta, 1977; 493(1):69–77.
16.
Van HerleAJ, UllerRP, MatthewsNI, et al.Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest, 1973; 52(6):1320–1327.
17.
SchneiderAB, PervosR. Radioimmunoassay of human thyroglobulin: Effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab, 1978; 47(1):126–137.
18.
FavusMJ, SchneiderAB, StachuraME, et al.Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med, 1976; 294(19):1019–1025.
19.
DuffyBJJr, FitzgeraldPJ. Cancer of the thyroid in children: A report of 28 cases. J Clin Endocrinol Metab, 1950; 10(10):1296–1308.
20.
HempelmannLH. Risk of thyroid neoplasms after irradiation in childhood. Studies of populations exposed to radiation in childhood show a dose response over a wide dose range. Science, 1968; 160(3824):159–163.
21.
RefetoffS, HarrisonJ, KaranfilskiBT, et al.Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med, 1975; 292(4):171–175.
22.
KaplanMM, GarnickMB, GelberR, et al.Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med, 1983; 74(2):272–280.
23.
SchneiderAB, FavusMJ, StachuraME, et al.Incidence, prevalence and characteristics of radiation-induced thyroid tumors. Am J Med, 1978; 64(2):243–252.
24.
Shore-FreedmanE, AbrahamsC, RecantW, et al.Neurilemomas and salivary gland tumors of the head and neck following childhood irradiation. Cancer, 1983; 51(12):2159–2163.
25.
SchneiderAB, RonE, LubinJ, et al.Dose-response relationships for radiation- induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab, 1993; 77(2):362–369.
26.
RonE, LubinJH, ShoreRE, et al.Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res, 1995; 141(3):259–277.
27.
LubinJH, AdamsMJ, ShoreR, et al.Thyroid cancer following childhood low-dose radiation exposure: A pooled analysis of nine cohorts. J Clin Endocrinol Metab, 2017; 102(7):2575–2583.
28.
NikiforovaMN, StringerJR, BloughR, et al.Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science, 2000; 290(5489):138–141.
29.
ReynoldsT. Final report of Hanford thyroid disease study released. J Natl Cancer Inst, 2002; 94(14):1046–1048.
30.
HoffmanFO, RuttenberAJ, ApostoaeiAI, et al.The Hanford thyroid disease study: An alternative view of the findings. Health Phys, 2007; 92(2):99–111.
31.
WangZY, BoiceJDJr, WeiLX, et al.Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst, 1990; 82(6):478–485.
32.
RobbinsJ, SchneiderAB. Radioiodine-induced thyroid cancer: Studies in the aftermath of the accident at Chernobyl. Trends Endocrinol Metab, 1998; 9(3):87–94.
33.
LikhtarevIA, GulkoGM, KairoIA, et al.Thyroid doses resulting from the Ukraine Chernobyl accident–Part I: Dose estimates for the population of Kiev. Health Phys, 1994; 66(2):137–146.
34.
TronkoMD, BogdanovaTI, KomissarenkoIV, et al.Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: Statistical data and clinicomorphologic characteristics. Cancer, 1999; 86(1):149–156.
35.
BeckerDV, BravermanLE, DunnJT, et al.The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association. JAMA, 1984; 252(5):659–661.
36.
ToftDJ, SchneiderAB. Protecting the thyroid in times of conflict (Ukraine 2022). Thyroid, 2022; 32(6):607–610.
37.
ClementSC, KremerLCM, VerburgFA, et al.Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treat Rev, 2018; 63:28–39.
